News Janux Therapeutics, Inc.

Equities

JANX

US47103J1051

Real-time Estimate Cboe BZX Other stock markets 11:29:04 2024-05-03 am EDT			5-day change	1st Jan Change
62.46 ^USD	+0.04%		+31.74%	+481.83%

Apr. 16	JonesTrading Starts Janux Therapeutics With Buy Rating, $70 Price Target	MT
Apr. 10	Sector Update: Health Care Stocks Slipping Late Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JonesTrading Starts Janux Therapeutics With Buy Rating, $70 Price Target	Apr. 16	MT
Sector Update: Health Care Stocks Slipping Late Afternoon	Apr. 10	MT
Sector Update: Health Care	Apr. 10	MT
Janux Therapeutics Said to be Considering Sale	Apr. 10	MT
Janux Therapeutics Considering Options, Including Sale, Bloomberg Reports	Apr. 10	MT
BTIG Starts Janux Therapeutics With Buy Rating, $62 Price Target	Mar. 21	MT
Cantor Fitzgerald Starts Janux Therapeutics With Overweight Rating, $100 Price Target	Mar. 20	MT
H.C. Wainwright Adjusts Price Target on Janux Therapeutics to $50 From $35, Keeps Buy Rating	Mar. 11	MT
Janux Therapeutics Q4 Net Loss Narrows, Revenue Decreases	Mar. 08	MT
Janux Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 08	CI
Janux Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 08	CI
Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	Mar. 08	BU
Janux Therapeutics Prices $296.5 Million Offering of Common Stock, Pre-Funded Warrants	Feb. 29	MT
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants	Feb. 29	BU
Janux Therapeutics Announces Proposed Public Offering of Common Stock	Feb. 27	BU
Sector Update: Health Care Stocks Ease Late Afternoon	Feb. 27	MT
Sector Update: Health Care	Feb. 27	MT
Top Midday Gainers	Feb. 27	MT
Janux Therapeutics Shares Soar After Wedbush Boosts Price Target Following 'Positive' Data From Two Cancer Studies	Feb. 27	MT
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Data for Rate-Cut Hints	Feb. 27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Janux Therapeutics, Inc.

Equities

JANX

US47103J1051

Summary

Filters